89bio Statistics
Share Statistics
89bio has 148.31M
shares outstanding. The number of shares has increased by 37.84%
in one year.
| 148.31M |
| 37.84% |
| 0% |
| 99.99% |
| 145.86M |
| 22 |
| n/a |
Short Selling Information
The latest short interest is 15.61M, so 10.52% of the outstanding
shares have been sold short.
| 15.61M |
| 10.52% |
| 14.56% |
| 9.05 |
Valuation Ratios
The PE ratio is -2.23 and the forward
PE ratio is -3.81.
89bio's PEG ratio is
-0.03.
| -2.23 |
| -3.81 |
| 0 |
| 368.3 |
| 2.04 |
| -2.23 |
| -0.03 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 89bio.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 13.19,
with a Debt / Equity ratio of 0.09.
| 13.19 |
| 13.19 |
| 0.09 |
| -0.1 |
| -0.1 |
| -101.57 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-3.95M |
| 93 |
| 0 |
| n/a |
Taxes
| 692K |
| -0.19% |
Stock Price Statistics
The stock price has increased by 4.72% in the
last 52 weeks. The beta is 1.27, so 89bio's
price volatility has been higher than the market average.
| 1.27 |
| 4.72% |
| 9.65 |
| 8.72 |
| 43.44 |
| 1,683,216 |
Income Statement
| n/a |
| -38K |
| -384.66M |
| -367.08M |
| -384.66M |
| -371.68M |
| -3.51 |
Full Income Statement Balance Sheet
The company has 126.06M in cash and 37.55M in
debt, giving a net cash position of 88.51M.
| 126.06M |
| 37.55M |
| 88.51M |
| -824.51M |
| 603.49M |
| 561.91M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -367.82M
and capital expenditures -15K, giving a free cash flow of -367.84M.
| -367.82M |
| -15K |
| -367.84M |
| -3.51 |
Full Cash Flow Statement Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |